A new study reveals a previously overlooked weakness in certain cancer cells that could help researchers refine targeted treatments and reduce harmful side effects. Cancer cells that have lost one safeguard against DNA damage can become dependent on another, an enzyme called Wee1. Drugs that block Wee1 aim to exploit that weakness, but serious side […]
Fox Style News Syndicate. Sourced from broadcast reporting: Read Full Source Coverage.